Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study Longitudinal trajectories ...
In a world where diversity in cognitive and sensory experiences is becoming increasingly recognized, the importance of giving children—whether neurodivergent or neurotypical—effective adaptive tools ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results